189 related articles for article (PubMed ID: 31400712)
21. Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
Infante JB; Esteves GV; Raposo J; de Lacerda JF
Eur J Haematol; 2024 May; 112(5):840-844. PubMed ID: 38305491
[TBL] [Abstract][Full Text] [Related]
22. The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia.
Wang F; Jia JS; Wang J; Zhao T; Jiang Q; Jiang H; Zhu HH
Leuk Res; 2017 Oct; 61():84-88. PubMed ID: 28934679
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
24. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
Zhang Y; Wu S; Luo D; Zhou J; Li D
PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
[TBL] [Abstract][Full Text] [Related]
25. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
26. The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage.
Li H; Niu T; Huang J; Xie L; He C; Li J; Xiang B; Cui X; Wu Y; Tang Y; Jia Y; Liu Z; Ma H
Int J Hematol; 2023 Apr; 117(4):538-543. PubMed ID: 36522588
[TBL] [Abstract][Full Text] [Related]
27. Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Sui M; Wei H; Zhang Q; Xiu R; Shen X; Zhang Z; Zhou J
Hematology; 2021 Dec; 26(1):58-64. PubMed ID: 33402059
[TBL] [Abstract][Full Text] [Related]
28. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
[TBL] [Abstract][Full Text] [Related]
29. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
Zhao H; Sun J; Yan L; Jin B; Hou W; Cao F; Li H; Zhou J; Zhang Y
Ann Hematol; 2021 Jun; 100(6):1473-1483. PubMed ID: 33893844
[TBL] [Abstract][Full Text] [Related]
30. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
Mantha S; Goldman DA; Devlin SM; Lee JW; Zannino D; Collins M; Douer D; Iland HJ; Litzow MR; Stein EM; Appelbaum FR; Larson RA; Stone R; Powell BL; Geyer S; Laumann K; Rowe JM; Erba H; Coutre S; Othus M; Park JH; Wiernik PH; Tallman MS
Blood; 2017 Mar; 129(13):1763-1767. PubMed ID: 28082441
[TBL] [Abstract][Full Text] [Related]
31. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
Baysal M; Gürsoy V; Hunutlu FC; Erkan B; Demirci U; Bas V; Gulsaran SK; Pinar IE; Ersal T; Kirkizlar TA; Atli EI; Kirkizlar HO; Ümit EG; Gürkan H; Ozkocaman V; Ozkalemkas F; Demir AM; Ali R
Ann Hematol; 2022 May; 101(5):1049-1057. PubMed ID: 35190843
[TBL] [Abstract][Full Text] [Related]
32. Successful Treatment of Acute Promyelocytic Leukemia Complicated with Endometrial Cancer by Arsenic Trioxide.
Sugiura H; Nishimori H; Matsuoka H; Nakamura K; Fujii K; Fujii N; Matsuoka KI; Maeda Y
Acta Med Okayama; 2021 Apr; 75(2):219-224. PubMed ID: 33953429
[TBL] [Abstract][Full Text] [Related]
33. Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
Guo M; Wang B; Liu S; Wang W; Gao C; Hu S; Fan S; Hai X; Zhou J
Expert Rev Clin Pharmacol; 2019 Apr; 12(4):371-378. PubMed ID: 30795697
[TBL] [Abstract][Full Text] [Related]
34. Long-term survey of outcome in acute promyelocytic leukemia: a single center experience in 340 patients.
Liu YJ; Wu DP; Liang JY; Qiu HY; Jin ZM; Tang XW; Fu CC; Ma X
Med Oncol; 2011 Dec; 28 Suppl 1():S513-21. PubMed ID: 21069477
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
[TBL] [Abstract][Full Text] [Related]
36. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
Rajpurkar M; Alonzo TA; Wang YC; Gerbing RB; Gamis AS; Feusner JH; Gregory J; Kutny MA
J Pediatr Hematol Oncol; 2019 Jan; 41(1):51-55. PubMed ID: 30095694
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.
Lou Y; Ma Y; Suo S; Ni W; Wang Y; Pan H; Tong H; Qian W; Meng H; Mai W; Huang J; Yu W; Wei J; Mao L; Jin J
Leuk Res; 2015 Sep; 39(9):938-44. PubMed ID: 26183877
[TBL] [Abstract][Full Text] [Related]
38. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
39. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
Zhao S; Ge Y; Li Z; Yang T
Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
[TBL] [Abstract][Full Text] [Related]
40. Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).
Hassan IB; Zaabi MRA; Alam A; Hashim MJ; Tallman MS; Kristensen J
Int J Hematol; 2017 Jul; 106(1):90-98. PubMed ID: 28293819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
